Evidence map›Paper›PMID 29167819›Full record

ArticleNPJ microgravity2017

Successful amplification of DNA aboard the International Space Station.

Anna-Sophia Boguraev, Holly C Christensen, Ashley R Bonneau, John A Pezza, Nicole M Nichols, Antonio J Giraldez, Michelle M Gray, Brandon M Wagner, Jordan T Aken, Kevin D Foley and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in NPJ microgravity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Space Medicines for Space Health.ACS medicinal chemistry letters · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Anna-Sophia BoguraevYale University, New Haven, CT USA.
Holly C ChristensenDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA USA.
Ashley R BonneauDepartment of Genetics, Yale University School of Medicine, New Haven, CT USA.
John A PezzaNew England Biolabs, Inc., Ipswich, MA USA.
Nicole M NicholsNew England Biolabs, Inc., Ipswich, MA USA.
Antonio J GiraldezDepartment of Genetics, Yale University School of Medicine, New Haven, CT USA.
Michelle M GrayBoeing, Houston, TX USA.
Brandon M WagnerBoeing, Houston, TX USA.
Jordan T AkenBoeing, Houston, TX USA.
Kevin D FoleyBoeing, Houston, TX USA.
D Scott CopelandBoeing, Houston, TX USA.
Sebastian KravesminiPCR, Cambridge, MA USA.
Ezequiel Alvarez SaavedraminiPCR, Cambridge, MA USA.ORCID 0000-0001-9148-0879
Boeing (United States) · USYale University · USMassachusetts Institute of Technology · USNew England Biolabs (United States) · USWhitehead Institute for Biomedical Research · US

Funding

PRE-DOCTORAL TRAINING IN THE BIOLOGICAL SCIENCEST32GM007287 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BELL, STEPHEN P., KEATING, AMY E · 1985 to 2019
$40.8M
NIGMS NIH HHS T32 GM007287
6 · The paper itself

Abstract

As the range and duration of human ventures into space increase, it becomes imperative that we understand the effects of the cosmic environment on astronaut health. Molecular technologies now widely used in research and medicine will need to become available in space to ensure appropriate care of astronauts. The polymerase chain reaction (PCR) is the gold standard for DNA analysis, yet its potential for use on-orbit remains under-explored. We describe DNA amplification aboard the International Space Station (ISS) through the use of a miniaturized miniPCR system. Target sequences in plasmid, zebrafish genomic DNA, and bisulfite-treated DNA were successfully amplified under a variety of conditions. Methylation-specific primers differentially amplified bisulfite-treated samples as would be expected under standard laboratory conditions. Our findings establish proof of concept for targeted detection of DNA sequences during spaceflight and lay a foundation for future uses ranging from environmental monitoring to on-orbit diagnostics.

Identifiers

PMID29167819
PMCPMC5691047
OpenAlexW2761971078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.